Corvus (CRVS) news
Recent news
L3Harris delivering counter-drone systems to US Army
L3Harris Technologies (NYSE: LHX) has significantly expanded its production of VAMPIRE counter-unmanned systems (C-UxS) to meet growing demand from the U.S. Army and its allies. The company recently initiated high-volume manufacturing of the VAMPIRE system at its facility in Huntsville, Alabama, to…
AInvest Wire · Jun 10, 2026Corvus Pharmaceuticals - participates in $13.5 mln financing for Angel Pharmaceuticals
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) has been actively involved in the development and strategic expansion of its pipeline through its partnership with Angel Pharmaceuticals, a China-based biopharmaceutical company. In October 2020, Corvus co-founded Angel Pharmaceuticals and secured a 49.7%…
AInvest Wire · Jun 9, 2026Corvus Pharma announces additional investment in Angel Pharma
AInvest Wire · Jun 9, 2026Corvus Pharmaceuticals announces additional investment in Angel Pharmaceuticals to advance the development of Soquelintinib in China
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) has announced an additional investment in its partner, Angel Pharmaceuticals, to further the development of soquelitinib in China. The initiative follows the approval of an IND application by the Center for Drug Evaluation (CDE) of the China National…
AInvest Wire · Jun 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.